glp-1 for arthritis and Inflammation: How These Drugs Ease Beyond weight loss: GLP-1 emerges
Description
Another systematic review of randomized trials found that muscle-related indices often exceeded the usual benchmark of about 25% of weight loss coming from fat-free mass
GLP-1 receptor agonists such as semaglutide and tirzepatide support weight loss and blood sugar control by increasing satiety and improving glucose regulation
Im not sponsored, and no one paid me to say this
FDA Concerns Surrounding Compounded GLP-1 In a May 16, 2025 statement, the U.S
GLP-1 receptor agonists do not increase the risk of diverticular disease (diverticulosis or diverticulitis) in adults with type 2 diabetes
